In a boon to patients suffering from Parkinson’s Disease, advanced third-generation D-mine apomorphine pumps and pens (injections) manufactured by German pharma major Ever Pharma was recently launched by Celera Neuro Sciences in Bengaluru.
The state-of-the-art apomorphine-delivery devices, widely used in Europe, were unveiled by Dr K Sudhakar, Minister of Medical Education & Health, Govt of Karnataka, at a symposium on Parkinson's Disease in Bengaluru, organised by King's College London (KCL) and Parkinson's Research Alliance of India (PRAI).
The third-generation D-mine apomorphine pumps, widely used in Europe, can be self-handled by patients in five easy steps, with much less patient training needed.
The pump-filling process is controlled electronically, with much higher safety and convenience, compared to pumps which are operated manually, with cumbersome procedures. D-mine pumps are pre-filled and offer a continuous infusion of apomorphine, leading to absorption within five minutes. The oral pill burden of patients also comes down substantially.
